Jonathan G. Drachman, President and CEO at Neoleukin Therapeutics, Inc. (NLTX), bought 50,000 shares at $9.61 ($475K) on 2021-06-04, disclosed to the SEC on 2021-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.48 | 40,000 | $379K | 79.8% |
| 2 | $9.61 | 10,000 | $96K | 20.2% |
| Total | $9.51 avg | 50,000 | $475K | 100% |
| Filing → |
| NLTX | BUY | 2019-12-20 | $2.0M | — | Filing → |
| NLTX | BUY | 2019-09-11 | $1.6M | — | Filing → |
| SGEN | SELL | 2018-03-07 | $725K | — | Filing → |